InvestorsHub Logo
Followers 54
Posts 4814
Boards Moderated 0
Alias Born 05/17/2011

Re: None

Wednesday, 04/18/2012 10:07:13 AM

Wednesday, April 18, 2012 10:07:13 AM

Post# of 72077
SurgLine International, Inc. Update On New Revenues

SurgLine International, Inc. (SGLN.PK)

Thomas Toland, CEO of SGLN and SurgLine, Inc. ("SurgLine") reported that the company has successfully completed its first sports medicine related surgical case to a physician owned surgery center in the state of Indiana. The case involved specialized plates and screws and provided a substantial savings over the competition.

Toland was quoted as saying "We been working diligently with this cost containment consulting firm for more than 8 months on multiple projects around the U.S. and that this first case demonstrates our value proposition of "More Savings for Your Healthcare Dollar." We have been working side-by-side with the senior management team of this consulting firm to deliver proven savings in the operating room since last fall and we can now report success with our first of many cases. We are awaiting responses from others facilities as we speak."

Toland was further quoted as saying, "The sales cycle has been somewhat longer than what we initially anticipated. We must patiently understand that while we are setting the traditional medical supply chain process on its head by providing such high quality products and significant savings to these facilities that in many cases these same facilities may require layers of approval to occur in order to achieve our initial sales approval and resulting orders from these facilities."

Toland concluded, "In addition to the sports medicine surgical case referenced above, we have provided additional detailed pricing quotes on our spinal implant products to several acute care hospitals and physician owned surgery centers around the U.S. in conjunction with this cost containment consulting firm. We anticipate many more opportunities to provide quotations resulting in savings that can range from 25% to 40% or more depending upon the location and situation and implant selected."